Vertaling van "tumour cervix " (Engels → Nederlands) :

TERMINOLOGIE

Maternal care for:polyp of cervix | previous surgery to cervix | stricture or stenosis of cervix | tumour of cervix
indicatie voor zorg bij moeder wegens | cervixpoliep | indicatie voor zorg bij moeder wegens | cervixstrictuur of -stenose | indicatie voor zorg bij moeder wegens | cervixtumor | indicatie voor zorg bij moeder wegens | vroegere cervixoperatie

A rare subtype of mixed epithelial-mesenchymal tumour, often presenting as a large, exophytic polypoid lesion, which may extend through the cervix, composed of benign or atypical epithelium and low-grade malignant stroma. It usually presents with dys
zeldzaam adenosarcoom van baarmoederlichaam

adenocarcinoma in situ of the cervix | AIS of the cervix
in situ adenocarcinoom van de baarmoederhals | in situ adenocarcinoom van de cervix uteri

An extremely rare tumour association characterised by dual predisposition to melanoma and neural system tumours (typically astrocytoma). Fewer than 20 affected families have been reported to date. Affected individuals had cutaneous melanoma in associ
melanoom en tumor van zenuwstelsel-syndroom

nephroblastoma | Wilms tumour | Wilms' tumour | WT [Abbr.]
nefroblastoom | tumor van Birch-Hirschfeld | Wilmstumor

tumour marker | tumour marker protein
tumor marker | tumormerkstof

cervix uteri | womb neck
cervix uteri | baarmoederhals

Malignant mast cell tumour
mestceltumor, maligne

Burkitt's tumour
Burkitt-lymfoom

A rare hepatic tumour that may manifest with abdominal pain or fullness, as well as diarrhoea or weight loss. More than 10% of cases are asymptomatic and in rare cases a carcinoid syndrome may be observed. The age of onset is variable. The aetiology
primair neuro-endocrien carcinoom van lever

IN-CONTEXT TRANSLATIONS

Presence, or previous history, of malignant disease, except for primary basal cell carcinoma, carcinoma in situ of the uterine cervix, and some primary tumours of the central nervous system that have to be evaluated according to scientific evidence.
Aanwezigheid of voorgeschiedenis van maligne aandoeningen, met uitzondering van primair basaalcelcarcinoom, carcinoma in situ van de cervix uteri en enkele primaire tumoren van het centrale zenuwstelsel die aan de hand van de wetenschappelijke kennis moeten worden beoordeeld.

3. Presence or previous history of malignant disease, except for primary basal cell carcinoma, carcinoma in situ of the uterine cervix, and some primary tumours of the central nervous system that have to be evaluated according to the current consensus document of the Council of Europe ‘Standardisation of organ donor screening to prevent transmission of neoplasic diseases’.
3. aanwezigheid of voorgeschiedenis van maligne aandoeningen, met uitzondering van primair basaalcelcarcinoom, carcinoma in situ van de cervix uteri en enkele primaire tumoren van het centrale zenuwstelsel die aan de hand van het huidige consensusdocument van de Raad van Europa, "Standardisation of organ donor screening to prevent transmission of neoplastic diseases" zijn beoordeeld.

3. Presence or previous history of malignant disease, except for primary basal cell carcinoma, carcinoma in situ of the uterine cervix, and some primary tumours of the central nervous system that have to be evaluated according to the current consensus document of the Council of Europe "Standardisation of organ donor screening to prevent transmission of neoplasic diseases".
3. Aanwezigheid of voorgeschiedenis van maligne aandoeningen, met uitzondering van primair basaalcelcarcinoom, carcinoma in situ van de cervix uteri en enkele primaire tumoren van het centrale zenuwstelsel die aan de hand van het huidige consensusdocument van de Raad van Europa, "Standardisation of organ donor screening to prevent transmission of neoplastic diseases" zijn beoordeeld.